JF
PMVP icon

Jump Financial’s PMV Pharmaceuticals PMVP Stock Holding History

Jump Financial’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,873
Closed -$19.2K – 2019
2024
Q2 		$19.2K Buy
+11,873
New +$21.4K ﹤0.01% 1711
2022
Q4 		– Sell
-29,676
Closed -$353K – 1934
2022
Q3 		$353K Buy
+29,676
New +$429K 0.01% 1057
2022
Q1 		– Sell
-14,593
Closed -$337K – 1827
2021
Q4 		$337K Buy
+14,593
New +$353K 0.02% 830

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jump Financial's PMVP Position: Q3 2024 in Review

Jump Financial sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 11,873 shares — an estimated $19.2K sold.

Jump Financial first reported a position in PMVP in Q4 2021 and held it in 3 quarters. The position peaked at $353K in Q3 2022. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • Jump Financial reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 11,873 PMV Pharmaceuticals shares in Q3 2024, an estimated $19.2K.
  • Jump Financial first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Jump Financial's PMV Pharmaceuticals position peaked at $353K in Q3 2022.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.